Featured Research

from universities, journals, and other organizations

Self-administered vaccine patch may protect against potentially pandemic flu viruses

Date:
September 9, 2010
Source:
American Society for Microbiology
Summary:
A self-administered patch containing tiny microneedles may effectively deliver influenza virus-like particles through the skin and protect against potentially pandemic flu viruses such as H5N1.

A self-administered patch containing tiny microneedles may effectively deliver influenza virus-like particles through the skin and protect against potentially pandemic flu viruses such as H5N1.

Researchers from the U.S. and abroad report their findings in the September 2010 issue of the journal Clinical Vaccine and Immunology.

In the United States, seasonal flu epidemics often result in over 200,000 hospitalizations and 36,000 deaths each year. New pandemic flu strains continue to emerge, such as the 2009 H1N1 virus that resulted in the first pandemic influenza outbreak in the 21st century. Conventional vaccination programs require a painful injection administered by medical personnel and can take months to develop, emphasizing the need for vaccines that can be rapidly produced at low cost and distributed within weeks.

Influenza virus-like particles (VLPs) are potentially promising vaccine candidates as they are non-infectious and have been shown to induce long-lasting immunity against pandemic influenza viruses. An abundance of dermal dendritic cells, important members of the skins' immune system, make the skin an appealing route for vaccine delivery.

In the study researchers vaccinated mice with microneedle patches containing influenza H5 VLPs derived from the H5N1 virus and found the resulting protective immunity to be equal to or higher than that induced from intramuscular inoculation. Significantly, human skin cells also responded to the influenza VLP vaccine delivered by the microneedle patch.

"Microneedle vaccination in the skin with H5 VLPs represents a promising approach for a self-administered vaccine against viruses with pandemic potential," say the researchers.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. J.-M. Song, Y.-C. Kim, A. S. Lipatov, M. Pearton, C. T. Davis, D.-G. Yoo, K.-M. Park, L.-M. Chen, F.-S. Quan, J. C. Birchall, R. O. Donis, M. R. Prausnitz, R. W. Compans, S.-M. Kang. Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice. Clinical and Vaccine Immunology, 2010; 17 (9): 1381 DOI: 10.1128/CVI.00100-10

Cite This Page:

American Society for Microbiology. "Self-administered vaccine patch may protect against potentially pandemic flu viruses." ScienceDaily. ScienceDaily, 9 September 2010. <www.sciencedaily.com/releases/2010/09/100908104340.htm>.
American Society for Microbiology. (2010, September 9). Self-administered vaccine patch may protect against potentially pandemic flu viruses. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2010/09/100908104340.htm
American Society for Microbiology. "Self-administered vaccine patch may protect against potentially pandemic flu viruses." ScienceDaily. www.sciencedaily.com/releases/2010/09/100908104340.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins